High Adherence to Rebif Seen With RebiSmart Use, Chats With Doctor
Regular feedback from doctors about dosing data and health status is associated with high and sustained treatment adherence to RebifĀ (interferon beta-1a) amongĀ multiple sclerosis (MS)Ā patients using the RebiSmart autoinjector, a two-year observational study shows. This study’s level of treatment adherence ā 97.9% ā was comparable or superior to the…